UnknownNot Applicable

Malignant Pediatric Pelvic Tumors: A Retrospective Study

Egypt90 participantsStarted 2016-01

Plain-language summary

The aim of the study is to retrospectively review data about malignancies that arise primarily in the pelvis and/or in the pelvic organs, in pediatric cancer patients \& categorize the spectrum of these malignancies according to experience at South Egypt Cancer Institute which is the largest referral site in Upper Egypt.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients whose age less than 19 years. * Patients diagnosed with a primary malignant tumor in the pelvis and/or arising from the pelvic organs. Exclusion Criteria: * Patients whose age more than 18 years. * Patients diagnosed with a malignant disease primarily arising from the bone marrow.

What they're measuring

Overall survival (OS)

Timeframe: Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years

Event Free Survival (EFS)

Timeframe: Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years

Trial details

NCT IDNCT02557256

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11

View on ClinicalTrials.gov More Abdominal Neoplasms trials